Chromosome instability and tumor predisposition inversely correlate with BLM protein levels

DNA Repair

Volumn 2, Issue 12, 2003, Pages 1387-1404

  McDaniel, Lisa D ^a   Chester, Nicholas ^c   Watson, Mark ^a,b   Borowsky, Alexander D ^e   Leder, Philip ^c,d   Schultz, Roger A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blm protein; Bloom syndrome; Cancer; Chromosome instability; Hypomorph

Indexed keywords

PROTEIN; PROTEIN BLM; UNCLASSIFIED DRUG;

ALLELE; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; EXON; GENETIC STABILITY; GENOTYPE; IMMUNOHISTOCHEMISTRY; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ANIMALIA;

EID: 0345724846     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2003.08.006     Document Type: Article

References (38)

1. Chaganti R.S., Schonberg S., German J. A manyfold increase in sister chromatid exchanges in Bloom's syndrome. Proc. Natl. Acad. Sci. U.S.A. 71:1974;4508-4512.
2. Brat S.V. Sister chromatid exchange and cell cycle in fibroblasts of Bloom's syndrome. Hum. Genet. 48:1979;73-79.
3. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S. The Bloom's syndrome gene product is homologous to recq helicases. Cell. 83:1995;655-666.
4. Bahr A., De Graeve F., Kedinger C., Chatton B. Point mutations causing Bloom's syndrome abolish atpase and DNA helicase activities of the blm protein. Oncogene. 17:1998;2565-2571.
5. Gangloff S., McDonald J.P., Bendixen C., Arthur L., Rothstein R. The yeast type i topoisomerase top3 interacts with sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol. Cell. Biol. 14:1994;8391-8398.
6. Harmon F.G., DiGate R.J., Kowalczykowski S.C. Recq helicase and topoisomerase iii comprise a novel DNA strand passage function: a conserved mechanism for control of DNA recombination. Mol. Cell. 3:1999;611-620.
7. Hanada K., Ukita T.M., Kohno Y., Saito K., Kato J., Ikeda H. Recq DNA helicase is a suppressor of illegitimate recombination in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3860-3865.
8. Karow J.K., Chakraverty R.K., Hickson I.D. The Bloom's syndrome gene product is a 3′-5′ DNA helicase. J. Biol. Chem. 272:1997;30611- 30614.
9. Li J.L., Harrison R.J., Reszka A.P., Brosh R.M., Bohr V.A., Neidle S., Hickson I.D. Inhibition of the Bloom's and Werner's syndrome helicases by g-quadruplex interacting ligands. Biochemistry. 40:2001;15194-15202.
10. R.M. Brosh, A. Majumdar, S. Desai, I.D. Hickson, V.A. Bohr, M.M. Seidman, Unwinding of a DNA triple helix by the Werner and Bloom syndrome helicases, Biol. Chem. 276 (2001) 3024-3030.
11. Wang X.W., Tseng A., Ellis N.A., Spillare E.A., Linke S.P., Robles A.I., Seker H., Yang Q., Hu P., Beresten S., Bemmels N.A., Garfield S., Harris C.C. Functional interaction of p53 and blm DNA helicase in apoptosis. J. Biol. Chem. 276:2001;32948-32955.
12. Garkavtsev I.V., Kley N., Grigorian I.A., Gudkov A.V. The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control. Oncogene. 20:2001;8276-8280.
13. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, J. Qin Basc, a super complex of brca1-associated proteins involved in the recognition and repair of aberrant DNA structures, Gen. Dev. (2000) 8.
14. Franchitto A., Pichierri P. Protecting genomic integrity during DNA replication: correlation between Werner's and Bloom's syndrome gene products and the mre11 complex. Hum. Mol. Genet. 11:2002;2447-2453.
15. Beamish H., Kedar P., Kaneko H., Chen P., Fukao T., Peng C., Beresten S., Gueven N., Purdie N., Lees-Miller S., Ellis N.A., Kondo N., Lavin M.F. Functional link between blm defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, atm. J. Biol. Chem. 277:2002;30515-30523.
16. Chester N., Kuo F., Kozak C., O'Hara C.D., Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Gen. Dev. 12:1998;3382-3393.
17. Luo G., Santoro I., McDaniel L.D., Nishijima I., Mills M., Youssoufian H., Vogel H., Schultz R.A., Bradley A. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26:2000;424-429.
18. Goss K.H., Risinger M.A., Kordich J.J., Sanz M.M., Straughen J.E., Slovek L.E., Capobianco A.J., German J., Boivin G.P., Groden J. Enhanced tumor formation in mice heterozygous for blm mutation. Science. 297:2002;2051-2053.
19. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, J.D. Watson, Molecular Biology of the Cell, Garland, New York, 1983.
20. Seki T., Wang W., Okumura N., Seki M., Katada T., Enomoto T. Cdna cloning of mouse blm gene, the homologue to human Bloom's syndrome gene, which is highly expressed in the testis at the mrna level. Biochim. Biophys. Acta. 1398:1998;377-381.
21. Neff N.F., Ellis N.A., Ye T.Z., Noonan J., Huang K., Sanz M., Proytcheva M. The DNA helicase activity of blm is necessary for the correction of the genomic instability of Bloom syndrome cells. Mol. Biol. Cell. 10:1999;665-676.
22. U. Mohr, D.L. Dungworth, C.C. Capen, W.W. Carlton, J.P. Sundberg, J.M. Ward, Pathobiology of the Aging Mouse, ILSI Press, Washington, DC, 1996.
23. Cossee M., Puccio H., Gansmuller A., Koutnikova H., Dierich A., LeMeur M., Fischbeck K., Dolle P., Koenig M. Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet. 9:2000;1219-1226.
24. Rosen E.D. Gene targeting in hemostasis. Factor x. Frontiers Biosci. 7:2000;1915-1925.
25. Cui J., O'Shea K.S., Purkayastha A., Saunders T.L., Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor v. Nature. 384:1996;66-68.
26. Ibdah J.A., Paul H., Zhao Y., Binford S., Salleng K., Cline M., Matern D., Bennett M.J., Rinaldo P., Strauss A.W. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest. 107:2001;1403-1409.
27. Martin R.H., Rademaker A., German J. Chromosomal breakage in human spermatozoa, a heterozygous effect of the Bloom syndrome mutation. Am. J. Hum. Genet. 55:1994;1242-1246.
28. E.M. Kuhn, E. Therman, No increased chromosome breakage in three Bloom's syndrome heterozygotes, J. Med. Genet. 16 (1979) 219-222.
29. Tsuji H., Kojima T. Presence of abnormally high incidences of sister chromatid exchanges in three successive cell cycles in Bloom's syndrome lymphocytes. Chromosoma. 93:1985;87-93.
30. Rosin M.P., German J. Evidence for chromosome instability in vivo in Bloom syndrome: increased numbers of micronuclei in exfoliated cells. Hum. Genet. 71:1985;187-191.
31. Therman E., Kuhn E.M. Cytological demonstration of mitotic crossing-over in man. Cytogenet. Cell Genet. 17:1976;254-267.
32. Ockey C.H. Quantitative replicon analysis of DNA synthesis in cancer-prone conditions and the defects in Bloom's syndrome. J. Cell Sci. 40:1979;125-144.
33. Ockey C.H., Saffhill R. Delayed DNA maturation, a possible cause of the elevated sister-chromatid exchange in Bloom's syndrome. Carcinogenesis. 7:1986;53-57.
34. Lonn U., Lonn S., Nylen U., Winblad G., German J. An abnormal profile of DNA replication intermediates in Bloom's syndrome. Cancer Res. 50:1990;3141-3145.
35. Gruber S.B., Ellis N.A., Scott K.K., Almog R., Kolachana P., Bonner J.D., Kirchhoff T., Tomsho L.P., Nafa K., Pierce H., Low M., Satagopan J., Rennert H., Huang H., Greenson J.K., Groden J., Rapaport B., Shia J.R., Johnson S., Gregersen P.K., Harris C.C., Boyd J., Rennert G., Offit K. Blm heterozygosity and the risk of colorectal cancer. Science. 297:2002;2013.
36. Cleary S.P., Zhang W., Di Nicola N., Aronson M., Aube J., Steinman A., Haddad R., Redston M., Gallinger S., Narod S.A., Gryfe R. Heterozygosity for the blm(ash) mutation and cancer risk. Cancer Res. 63:2003;1769-1771.
37. Tsuda H., Takarabe T., Hasegawa F., Fukutomi T., Hirohashi S. Large central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am. J. Surg. Pathol. 24:2000;197-202.
38. Jones C., Foschini M.P., Chaggar R., Lu Y.J., Wells D., Shipley J.M., Eusebi V., Lakhani S.R. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab. Invest. 80:2000;831-836.